StepStone Group LP - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 54 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
StepStone Group LP ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,028,177
+4.4%
761,2770.0%2.68%
+25.7%
Q2 2023$11,525,734
+4.4%
761,2770.0%2.13%
+3.9%
Q1 2023$11,038,517
+7.2%
761,2770.0%2.05%
+52.7%
Q4 2022$10,292,465
-14.2%
761,2770.0%1.34%
-21.3%
Q3 2022$11,998,000
+55.1%
761,277
+19.9%
1.71%
+106.3%
Q2 2022$7,734,000
+8.2%
634,959
-16.6%
0.83%
+55.2%
Q1 2022$7,148,000
-45.2%
761,2770.0%0.53%
-28.3%
Q4 2021$13,033,000761,2770.74%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders